Home » Topics » BioWorld Science

BioWorld Science
RSS

Bioniz begins phase I/II study of BNZ-1 in LGL leukemia and refractory CTCL

Jan. 29, 2018

Phase I clinical data presented for E-7046 in patients with solid tumors

Jan. 29, 2018

Amgen explores use of AMG-757 in small cell lung cancer

Jan. 29, 2018

Clinical activity seen with encorafenib/binimetinib/cetuximab treatment in BEACON CRC trial

Jan. 29, 2018

FDA grants fast track designation to Traumakine for ARDS

Jan. 29, 2018

EMA committee recommends approval of Hemlibra in hemophilia A

Jan. 29, 2018

Merck Sharp & Dohme initiates phase I study of MK-4250 in ART-naive patients with HIV-1

Jan. 29, 2018

Survival data presented for patients with pancreatic cancer under CCX-872 therapy

Jan. 29, 2018

Sanofi set to acquire Ablynx

Jan. 29, 2018

Reolysin induces robust immune responses in patients with metastatic colorectal cancer

Jan. 29, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...